ADVB on Nasdaq
Advanced Biomed Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
-$3.3MNet income, fiscal 20252
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Research and development expenses | -$909.8K | -$880.2K |
| General and administrative expenses | -$2.1M | -$1.7M |
| Total operating expenses | -$3.0M | -$2.5M |
| Interest income | $24.9K | $53.5K |
| Other expense, net | -$262.8K | -$294.2K |
| Total other expense, net | -$237.9K | -$240.7K |
| Loss before tax expense | -$3.3M | -$2.8M |
| Net Loss | -$3.3M | -$2.8M |
| Foreign currency translation gain, net of taxes | $218.3K | $319.3K |
| Total comprehensive loss | -$3.0M | -$2.5M |
| Basic (in Dollars per share) | -$0.16 | -$0.14 |
| Diluted (in Dollars per share) | -$0.16 | -$0.14 |
| Basic (in Shares) | 20.5M shares | 20.0M shares |
| Diluted (in Shares) | 20.5M shares | 20.0M shares |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|
| Cash | $2.9M | ||
| Prepaid expenses and other current assets, net | $3.1M | ||
| Total current assets | $6.0M | ||
| Equipment, net | $331.3K | ||
| Right-of-use assets, net | $65.4K | ||
| Other non-current assets | $83.0K | ||
| Total non-current assets | $479.8K | ||
| TOTAL ASSETS | $6.5M | ||
| Accounts payable, accruals, and other current liabilities (including amount due to related parties major stockholders as of June 30, 2025 and 2024, with $172,767 and $113,812 due to related parties related corporations, and $916,036 and $674,262 due to related corporations, respectively (1)) | $2.9M | ||
| Lease payable - current | $35.8K | ||
| Total current liabilities | $2.9M | ||
| Lease payable non-current | $5.9K | ||
| Total non-current liabilities | $145.7K | ||
| TOTAL LIABILITIES | $3.0M | ||
| Common stock $0.001 par value per share; as of June 30, 2025 and 2024; 400,000,000 and 400,000,000 shares authorized; 21,640,000 and 20,000,000 shares issued and outstanding, respectively* | $21.6K | ||
| Additional paid-in capital | $21.3M | ||
| Accumulated deficits | -$19.2M | ||
| Accumulated other comprehensive income | $1.3M | ||
| Total stockholders equity | $3.5M | ||
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | $6.5M | ||
| Common stock, par value (in Dollars per share) | $0.00 | ||
| Common stock, shares authorized | 400.0M shares | ||
| Common stock, shares issued | 21.6M shares | 20.0M shares | 100.0M shares |
| Common stock, shares outstanding | 21.6M shares | 20.0M shares | 100.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Net loss | -$3.3M | -$2.8M |
| Depreciation and amortization | $343.8K | $399.6K |
| Prepaid expenses and other current assets | -$2.7M | -$279.4K |
| Accounts payable, accruals and other current liabilities | -$117.7K | $479.6K |
| Lease obligations, net cash | -$23.7K | |
| Other non-current assets | -$83.0K | $56.1K |
| Cash used in operating activities | -$5.8M | -$2.1M |
| Purchase of equipment | -$31.6K | -$74.1K |
| Cash used in investing activities | -$31.6K | -$74.1K |
| Net proceeds from issuance of stock in IPO/(prepayments for IPO costs) | $5.5M | -$85.4K |
| Cash provided by financing activities | $5.9M | $1.9M |
| Foreign currency effect | $218.3K | $319.3K |
| Net change in cash | $295.9K | -$14.3K |
| Cash received for interest | $24.9K |
Recent filings
- Oct 13, 202610-K ANNUAL REPORT
- Sep 28, 2026NT 10-K
- Sep 22, 2026SCHEDULE 13G
- Aug 20, 2026SCHEDULE 13G
- Aug 20, 2026SCHEDULE 13G/A
- Aug 20, 20264
- Jul 20, 2026RW WITHDRAWAL REQUEST
- Jul 17, 20268-K CURRENT REPORT
- Jul 1, 20268-K CURRENT REPORT
- Jun 30, 20268-K CURRENT REPORT
- Jun 4, 2026DEF 14A DEFINITIVE PROXY STATEMENT
- May 15, 202610-Q QUARTERLY REPORT
- May 1, 20268-K CURRENT REPORT
- Apr 14, 20268-K CURRENT REPORT
- Apr 3, 20268-K CURRENT REPORT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7